The combined company will operate as Obsidian Therapeutics following the merger. Investors in the $350 million private ...
Leidos is spinning off its business unit that provides security screening at airports, borders and ports to sharpen its focus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results